CASTIGLIA, Marta
CASTIGLIA, Marta
Biomedicina, Neuroscienze e Diagnostica avanzata
A headlight on liquid biopsies: a challenging tool for breast cancer management
2016-01-01 Massihnia, D.; Perez, A.; Bazan, V.; Bronte, G.; Castiglia, M.; Fanale, D.; Barraco, N.; Cangemi, A.; Di Piazza, F.; Calò, V.; Rizzo, S.; Cicero, G.; Pantuso, G.; Russo, A.
Adipose tissue, angiogenesis and angio-MIR under physiological and pathological conditions
2018-01-01 Di Stefano AB, Massihnia D, Grisafi F, Castiglia M, Toia F, Montesano L, Russo A, Moschella F, Cordova A.
ALK and crizotinib: After the honeymoon...what else? Resistance mechanisms and new therapies to overcome it
2014-01-01 Rolfo, Christian*; Passiglia, Francesco; Castiglia, Marta; Raez, Luis E.; Germonpre, Paul; Gil-Bazo, Ignacio; Zwaenepoel, Karen; De Wilde, Annemieke; Bronte, Giuseppe; Russo, Antonio; Van Meerbeeck, Jan P.; Van Schil, Paul; Pauwels, Patrick
An update on the conquests and perspectives of cardio-oncology in the field of tumor angiogenesistargeting TKI-based therapy
2019-01-01 Antonio Galvano, Aurelia Guarini, Federica Iacono, Marta Castiglia, Sergio Rizzo, Luigi Tarantini, Stefania Gori, Giuseppina Novo, Viviana Bazan, Antonio Russo
Analysis of tissue and circulating microRNA expression during metaplastic transformation of the esophagus
2016-01-01 Cabibi, D.; Caruso, S.; Bazan, V.; Castiglia, M.; Bronte, G.; Ingrao, S.; Fanale, D.; Cangemi, A.; Calò, V.; Listì, A.; Incorvaia, L.; Galvano, A.; Pantuso, G.; Fiorentino, E.; Castorina, S.; Russo, A.
Are erlotinib and gefitinib interchangeable, opposite or complementary for non-small cell lung cancer treatment? Biological, pharmacological and clinical aspects
2014-01-01 Bronte, G; Rolfo, C; Giovannetti, E; Cicero, G; Pauwels, P; Passiglia, F; Castiglia, M; Rizzo, S; Lo Vullo, F; Fiorentino, E; Van Meerbeeck, J; Russo, A
CALR MUTATIONS IN SICILIAN ESSENTIAL THROMBOCYTHEMIA AND MYELOFIBROSIS PATIENTS.
Di Piazza, F.; Accurso, V.; Caracciolo, C.; Mulè, L.; Bono, M.; Perez, A.; Castiglia, M.; Calò, V.; Massiccia, D.; Barraco, N.; Cangemi, G.; Maragliano, R.; Listi', A.; Galluccio, N.; Bazan, V.; Siracusa, S.; Russo, A.
Can the microRNA expression profile help to identify novel targets for zoledronic acid in breast cancer?
2016-01-01 Fanale, D.; Amodeo, V.; Bazan, V.; Insalaco, L.; Incorvia L; Barraco, N.; Castiglia, M.; Rizzo, S.; Santini, D.; Giordano, A.; Castorina, S.; Russo, A.
Cancer and the microbiome: Potential applications as new tumor biomarker
2015-01-01 Shahanavaj, K.; Gil-Bazo, I.; Castiglia, M.; Bronte, G.; Passiglia, F.; Carreca, A.; Del Pozo, J.; Russo, A.; Peeters, M.; Rolfo, C.
Cell quality evaluation with gene expression analysis of spheroids (3D) and adherent (2D) adipose stem cells
2020-01-01 Di Stefano AB, Grisafi F, Perez-Alea M, Castiglia M, Di Simone M, Meraviglia S, Cordova A, Moschella F, Toia F.
Circulating tumor DNA (ctDNA) as predictive biomarker in NSCLC patients treated with Nivolumab
2017-01-01 Passiglia, F.; Perez, A.; Listi', A.; Castiglia, M.; Musso, E.; Ancona, C.; Rizzo, S.; Alù, M.; Blasi, L.; Russo, A.
Corrigendum to "Liquid biopsies in lung cancer: The new ambrosia of researchers" [Biochem. Biophys. Act. 1846(2014) 539-546]
2015-01-01 Rolfo C.; Castiglia M.; Hong D.; Alessandro R.; Mertens I.; Baggerman G.; Zwaenepoel K.; Gil-Bazo I.; Passiglia F.; Carreca A.P.; Taverna S.; Vento R.; Santini D.; Peeters M.; Russo A.; Pauwels P.
Dietary restriction: could it be considered as speed bump on tumor progression road?
2016-01-01 Cangemi, A.; Fanale, D.; Rinaldi, G.; Bazan, V.; Galvano, A.; Perez, A.; Barraco, N.; Massihnia, D.; Castiglia, M.; Vieni, S.; Bronte, G.; Mirisola, M.; Russo, A.
E26The effects of LIPUS on ctDNA release in the medium of NSCLC cell lines
2017-01-01 Perez, A.; DI STEFANO, A.; Castiglia, M.; Sorrentino, M.; Matranga, D.; Grisafi, F.; Corso, C.; Scoarughi, G.; Barbato, G.; Barraco, N.; Calo', V.; DI PIAZZA, F.; Massihnia, D.; Listi', A.; Castellana, L.; Guarini, A.; Insalaco, L.; Bronte, E.; Russo, A.
EFFECT OF miR-21, miR-182 AND let-7i ON TSP-1 EXPRESSION IN COLON CANCER CELL LINE
2010-01-01 Amodeo, V; Insalaco, L; Terrasi, M; Fanale, D; Margarese, N; La Paglia, L; Corsini, L; Napoli, L; Damiani, G; Castiglia, M; Di Piazza, F; Miraglia, M; Bazan, V; Russo, A
EGFR inhibition in NSCLC: New findings…. and opened questions?
2017-01-01 Passiglia, F.; Listì, A.; Castiglia, M.; Perez, A.; Rizzo, S.; Bazan, V.; Russo, A.
Erratum to: The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis (Scientific Reports, (2018), 8, 1, (13379), 10.1038/s41598-018-30780-4)
2018-01-01 Passiglia F.; Rizzo S.; Di Maio M.; Galvano A.; Badalamenti G.; Listi A.; Gulotta L.; Castiglia M.; Fulfaro F.; Bazan V.; Russo A.
Exosomal miRNA analysis in non-small cell lung cancer (NSCLC) patients' plasma through qPCR: A feasible liquid biopsy tool
2016-01-01 Giallombardo, Marco; Borrás, Jorge Chacártegui; Castiglia, Marta; Van Der Steen, Nele; Mertens, Inge; Pauwels, Patrick; Peeters, Marc; Rolfo, Christian
Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice
2016-01-01 Taverna, S.; Giallombardo, M.; Gil-Bazo, I.; Carreca, A.; Castiglia, M.; Chacártegui, J.; Araujo, A.; Alessandro, R.; Pauwels, P.; Peeters, M.; Rolfo, C.
Hereditary breast and ovarian cancer in families from southern Italy (Sicily)—Prevalence and geographic distribution of pathogenic variants in BRCA1/2 genes
2020-01-01 Incorvaia L.; Fanale D.; Badalamenti G.; Bono M.; Calo V.; Cancelliere D.; Castiglia M.; Fiorino A.; Pivetti A.; Barraco N.; Cutaia S.; Russo A.; Bazan V.